CPhI Announces 2014 Expert Industry Panel

Amsterdam (ots/PRNewswire) -

Panel to contribute to Pharma Insights reports and second addition
of the

CPhI annual report due to be launched at CPhI Worldwide 2014

Panel members for 2014:

- Prabir Basu, President at Pharma Manufacturing
- Girish Malhotra, President & Founder, Epcot International
[http://www.pharmaevolution.com/bloggers.asp#Girish_Malhotra ]
- Hedley Rees, Managing Director at PharmaFlow Ltd
- Ajaz Hussain, CSO & President Biotechnology at Wockhardt
- Sam Venugopal, Director in the Healthcare Practice at PWC
- William Botha, Consultant and Founder Interlean
- Emil Ciurczak, President at Doramaxx Consulting
- Dilip G Shah, CEO of Vision Consulting Group and a regulatory expert
- Vijay Shah, COO at Piramal Enterprises and pharma business lead

CPhI Worldwide [http://www.cphi.com ], organised by UBM Live,
announces its initial line-up of confirmed expert industry panel
members for 2014 - building on the huge success of the CPhI annual
report launched at CPhI Worldwide in October 2013.

(Logo: http://photos.prnewswire.com/prnh/20130723/629764-a )

This year's panel sees the return of nine thought leaders, with
further members joining imminently. Additionally, this year panel
members will also be utilising their market insights and analysis
year-round in the CPhI Pharma Insights series, which covers
individual topics and developments across the industry - including
the recently launched R&D and manufacturing reports.

Expertise ranges from API and manufacturing efficiencies (Girish
Malhotra) to quality systems and supply chain activities (Sam
Venugopal), with insights also provided from some of the sectors'
biggest names and innovators, like Piramal's Vijay Shah. In addition,
the panel features regulatory heavyweight Ajaz Hussain of Wockhardt -
renowned for coining the term PAT - who will lend his expertise on
establishing and improving drug regulation. Across supply chain
issues, the panel will leverage the knowledge of Hedley Rees, whilst
Prabir Basu, formerly of the National Institute for Pharmaceutical
Technology and Education (NIPTE), will focus on the industry's
approach to innovation.

Regulatory expert, predominantly focussed on the Indian market,
Dilip Shah also returns, covering the intellectual property rules
around innovation.

Emil Ciurczak, also previously a member of the FDA's PAT committee
and president of Doramaxx Consulting [http://www.linkedin.com/search
?search=&company=Doramaxx+Consulting&sortCriteria=R&keepFacets=true&t
rk=prof-exp-company-name ] , draws up his expertise across PAT, QbD
and spectroscopy. Finally, William Botha, a respected trainer and
mentor in manufacturing, is also retuning to the panel; he is fluent
in FDA regulations, including GDP and GMP.

Last year's report examined a number of major issues and
developments across the industry including cost savings through QbD
and PAT, to regulatory challenges from a globalised industry, right
through to the effect breakthrough drugs like ADCs will have on
overcoming future disease pathologies.

"Last year's report was a huge success with our experts, providing
a combined insight into the overall picture of the industry. What is
interesting this year is to see the progress the industry has made,
and what new problems or challenges there are. In the first annual
report insights spanned a mixture of practical manufacturing
improvements, like single-use reactors and continuous processing,
mixed with regulatory risks and the future potential of breakthrough
drugs like ADCs and supply chain issues. Everything from life-saving
drugs to an open assessment of where industry risks lay, and
culminating in the new business model emerging- with increased
partnerships, innovation sharing and consolidation. Further, our
experts offered conclusions on the necessary techniques, technologies
and a simplified regulatory approach that will simultaneously
increase safety and innovation," commented Chris Kilbee, Group
Director Pharma at CPhI.

The 2014 annual report will feature a collection of in-depth
essays from each panel member - with experts given carte blanche to
prophesize how the industry will look and operate in the future from
both an economic and practical perspective. Additionally, the CPhI
Pharma Insights reports contain a mixture of primary data (industry
surveys) and expert comment on what these findings show about the
general direction of the industry and any issues they feel need to be
addressed.

CPhI is now in the later stages of assembling the panel's full
line-up and plans to announce all participants in the summer - with a
few more global heavyweights expected.

Kilbee added: "I am delighted that we have been able to source so
many leading figures from within the industry to take part in the
panel, as collectively they bring a huge amount of experience and
insight. Already the panel's knowledge spans pharmaceutical
ingredients, manufacturing processes, global supply chain issues and
regulatory frameworks. One thing they all have in common is a wealth
of experience across international markets and a practical approach
to problem solving, which will be invaluable in postulating future
market dynamics."

For more information, please contact: cphi@ubm.com

About CPhI

CPhI drives growth and innovation at every step of the global
pharmaceutical supply chain from drug discovery to finished dosage.
Through exhibitions, conferences and online communities, CPhI brings
together more than 100,000 pharmaceutical professionals each year to
network, identify business opportunities and expand the global
market. CPhI hosts events in Europe, China, India, Japan, Southeast
Asia, Istanbul, Russia and South America and co-locates with ICSE for
contract services, P-MEC for machinery, equipment & technology,
InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI
provides an online buyer & supplier directory at CPhI-Online.com.

For more information visit: http://www.cphi.com

The UBM Live annual schedule of Pharmaceutical events also
includes CPhI Russia and IPhEB (16-17 April, 2014 at the Lenexpo
Exhibition Complex- St Petersburg, Russia); CPhI, P-MEC and Innopack
South East Asia (20-22 May, 2014 at the Jakarta International Expo-
Jakarta, Indonesia); CPhI Istanbul (4-6 June, 2014, at the Lutfi
Kirdar Convention and Exhibition Centre- Turkey); CPhI, Hi and Fi,
ICSE, P-MEC, BioPh and LabWorld China (26-28 June, 2014 at SNIEC-
Shanghai, China); CPhI South America (5-7 August 2014 at Expo Centre
Norte, Sao Paulo- Brazil); CPhI, ICSE Korea (2-3 September, 2014 at
the COEX- Seoul, South Korea); CPhI, ICSE, P-MEC and InnoPack
Worldwide ; CPhI and P-MEC India (2-4 December, 2014 at the Bombay
Exhibition Centre- Mumbai); CPhI, ICSE, P-MEC, BioPh and Pharmatec
Japan .

About UBM Live

UBM Live connects people and creates opportunities for companies
across five continents to develop new business, meet customers,
launch new products, promote their brands, and expand their market.
Through premier brands such as TFM&A, Internet World, IFSEC, MD&M,
CPhI, Cruise Shipping Miami, the Concrete Show, and many others, UBM
Live exhibitions, conferences, awards programs, publications,
Websites, and training and certification programs are an integral
part of the marketing plans of companies across more than 20 industry
sectors.

For media enquiries, please contact:
Alex Heeley or Tristan Jervis
De Facto Communications
T: +44(0)207-203-6745 / 6740
E: a.heeley@defacto.com / t.jervis@defacto.com

Photo:
http://photos.prnewswire.com/prnh/20130723/629764-a

ots Originaltext: UBM Live
Im Internet recherchierbar: http://www.presseportal.de